Long term clinical outcomes of home parenteral nutrition in Singapore.

Autor:	Cheah CCM; Department of Gastroenterology & Hepatology, Singapore General Hospital, Singapore., Ng HM; Department of Gastroenterology & Hepatology, Singapore General Hospital, Singapore., Chiou FK; Gastroenterology, Hepatology & Nutrition Service, Paediatric Medicine, KK Women's & Children's Hospital, Singapore., Logarajah V; Gastroenterology, Hepatology & Nutrition Service, Paediatric Medicine, KK Women's & Children's Hospital, Singapore., Salazar E; Department of Gastroenterology & Hepatology, Singapore General Hospital, Singapore. Email: ennaliza.salazar@singhealth.com.sg.
Jazyk:	angličtina
Zdroj:	Asia Pacific journal of clinical nutrition [Asia Pac J Clin Nutr] 2023; Vol. 32 (2), pp. 282-294.
DOI:	10.6133/apjcn.202306_32(2).0011
Abstrakt:	Background and Objectives: Home parenteral nutrition (HPN) is a life sustaining therapy for patients with chronic intestinal failure. Reported outcomes for Asian HPN patients are scarce. We aim to review the clinical outcomes of adult and paediatric HPN patients in our cohort which caters for 95% of Singaporean HPN patients. Methods and Study Design: This is a retrospective review of HPN patients from an adult (2002-2017) and paediatric cohort (2011-2017) from the largest tertiary PN centres in Singapore. Patient demographics and clinical outcomes were reviewed. Results: There were 41 adult and 8 paediatric HPN patients. Mean age was 53.0(±15.1) (adults) and 8(±1.8) years-old (paediatrics). Mean duration of HPN was 2.6(±3.5) and 3.5(±2.5) years. Leading indications for adult HPN were short bowel syndrome (SBS) (n=19,46.3%), mechanical obstruction (n=9,22.0%), and gastrointestinal dysmotility disorders (GID) (n=5,12.2%). Thirteen adult (31.7%) patients had underlying malignancy, with seven (17.3%) receiving palliative HPN. Indications for HPN amongst paediatric patients was GID (n=5,62.5%) and SBS (n=3,37.5%). Central line-associated bloodstream infection (CLABSI)/1000catheter-days was 1.0(±2.1) and 1.8(±1.3). Catheter associated venous thrombosis (CAVT)/1000catheter-days was 0.1(±0.4) and 0.7(±0.8). Biochemical Intestinal Failure Associated Liver Disease (IFALD) was found in 21.9% and 87.5%. For adults, median overall survival was 90-months (4.3,175.7,95%CI), with actuarial survival of 70.7%(1-year) and 39.0%(5-years). Median survival for adult patients with malignancy was 6-months (4.2,7.7,95%CI), actuarial survival of 85.7%(3-months) and 30.7%(1-year). One adult patient died from PN related complications. No paediatric deaths were noted. Conclusions: Whilst patient numbers were modest, we report comparable complication and survival rates to other international centres in both our adult and paediatric cohorts.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu